52-Week Performance Chart

Powered by FactSet Research Systems Inc

Capital Raising Events

More
DR Price Date DR Price (USD) US/Non-US/Total DRS US/Non-US/Total DR Capital Raised
May 23, 2023 .15 22,135,922
0
22,135,922
3,320,388
0
3,320,388

No DR Events are available.

No DR Events are available.

Data provided by Thomson Reuters

Institutional Ownership

TOP INSTITUTIONAL HOLDERS POSITION
UBS Securities LLC 7,047
GAMMA Investing LLC 1,426
RhumbLine Advisers LP 315
TOP MUTUAL FUND HOLDERS POSITION
Fidelity Nasdaq Composite Index Fund 78

Data provided by FactSet Research Systems Inc.

DR Details

DR Symbol BDRX
CUSIP 59564R807
DR Venue NASDAQ Stock Market
DR ISIN US59564R8079
Ratio DR:ORD 1:10000
Underlying ISIN GB00BNGF1L75
Country United Kingdom
Effective Date Dec 18, 2023
Depositary JPMC (Sponsored)
Industry Pharma. & Biotech.
Biodexa Pharmaceuticals is a holding company. Through its subsidiaries, the Company is focused on the research and development of medicines using its drug delivery technologies. These technologies include Q-Sphera (TM) platform, a disruptive polymer microsphere microtechnology used for sustained delivery to prolong and control the release of therapeutics over an extended period of time; MidaSolve (TM) platform, an oligosaccharide nanotechnology to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore (TM) platform, a gold nanoparticle nanotechnology used for targeting sites of disease by using either chemotherapeutic agents or immunotherapeutic agents.

Data provided by Mergent, Inc.

Fee Type in US Dollar per ADS Deposit Agreement
Cable Fee per Cancellation $17.5000

Monthly Trading Summary

More
Month Month End DR Close Price DR Trading Volume Avg Day DR Trading Volume
Apr.25 1.46 24,156,431 1,150,306
Mar.25 1.32 68,394,059 3,256,860
Feb.25 3.33 25,321,900 1,332,732

Powered by FactSet Research Systems Inc.

This information and data is provided for general informational purposes only.  Certain displayed prices may not reflect direct quotes from any market or exchange, but may instead reflect an approximation of price based on a methodology that includes a calculation that includes the price of underlying securities and foreign exchange rate selected for such purpose. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to Terms of Use

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE